Immunocore
Rob Perez is an Operating Partner and part of General Atlantic’s Operations Group, providing strategic support and advice to the firm’s investment team and portfolio companies with a particular focus on the biopharma and life sciences sectors. Before joining General Atlantic in 2019, he was Managing Director of Vineyard Sound Advisors, LLC, an advisory practice focused on growth companies in the biopharma industry. Prior to that, Rob was President and CEO of Cubist Pharmaceuticals, Inc. before its sale to Merck in 2015. Before joining Cubist in 2003, he served as Vice President of Biogen, Inc.’s CNS Business Unit.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Immunocore
1 followers
Immunocore is a privately owned British clinical-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs to treat cancer, infectious diseases and autoimmune diseases using soluble T-cell receptor technology.